APS Support UK/X
Aug 7, 2025, 00:59
Hydroxychloroquine in APS: Anti-Inflammatory and Antithrombotic Effects Supported by Recent Evidence
APS Support UK has shared a post on X:
“ NEW REVIEW | Hydroxychloroquine in APS
- HCQ shows anti-inflammatory/thrombotic effects
- Deacreases platelet aggregation, NET formation, complement (C3a/C5a)
- Supports use in OAPS ( higher birth rate in treated vs untreated: 67% vs 57%).”
Read the full article here.
Title: The Role of Hydroxychloroquine in the Management of Rheumatic Disorders: A Comprehensive Review
Authors: Ilker Ates, Hilal Sahin, Lalu Muhammad Irham, Serkan Yilmaz, Sinan Suzen
Stay updated with the latest scientific advances with Hemostasis Today.
-
Aug 22, 2026, 11:36Bernardo Gindri: How platelets Influence Cancer Progression
-
Aug 22, 2026, 11:34Nick Gehrig: Extending Platelet Shelf Life to Strengthen Blood Supply
-
Aug 22, 2026, 11:14Lei Yu: New Guidance for Acute Pulmonary Embolism in 2026
-
Aug 22, 2026, 11:01Neeraj Songara: Shelf-Stable Synthetic Blood – The Future of Emergency Transfusion?
-
Aug 22, 2026, 10:41Mike R.։ VTE Thrombectomy – Defining What Success Really Means
-
Aug 22, 2026, 10:28Steven Meier: What Happens During PRP Therapy?
-
Aug 22, 2026, 10:05Ralf Ludwig: When a Promising Biomarker Falls Short
-
Aug 22, 2026, 09:33Mary Cushman: What Causes PE to Happen in People with DVT?
-
Aug 22, 2026, 07:45Ziad Hijazi: Refining Risk Assessment in Atrial Fibrillation Without Oral Anticoagulation